These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17125266)

  • 21. Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
    Altenbach RJ; Khilevich A; Kolasa T; Rohde JJ; Bhatia PA; Patel MV; Searle XB; Yang F; Bunnelle WH; Tietje K; Bayburt EK; Carroll WA; Meyer MD; Henry R; Buckner SA; Kuk J; Daza AV; Milicic IV; Cain JC; Kang CH; Ireland LM; Carr TL; Miller TR; Hancock AA; Nakane M; Esbenshade TA; Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Holladay MW; Brioni JD; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3220-35. PubMed ID: 15163201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular properties of the WB4101 enantiomers and of its chiral methyl derivatives for alpha 1-adrenoceptor recognition.
    Villa L; Valoti E; Villa AM; Pallavicini M; Ferri V; Iuliano E; Brunello N
    Farmaco; 1994 Sep; 49(9):587-606. PubMed ID: 7811353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
    Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
    Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.
    Gentili F; Cardinaletti C; Vesprini C; Carrieri A; Ghelfi F; Farande A; Giannella M; Piergentili A; Quaglia W; Laurila JM; Huhtinen A; Scheinin M; Pigini M
    J Med Chem; 2008 Jul; 51(14):4289-99. PubMed ID: 18578476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.
    Hong SS; Bavadekar SA; Lee SI; Patil PN; Lalchandani SG; Feller DR; Miller DD
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4691-5. PubMed ID: 16153828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
    Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro".
    Colciago A; Mornati O; Ferri N; Castelnovo LF; Fumagalli L; Bolchi C; Pallavicini M; Valoti E; Negri-Cesi P
    Pharmacol Res; 2016 Jan; 103():215-26. PubMed ID: 26621245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
    Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
    J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist.
    Meyer MD; Altenbach RJ; Hancock AA; Buckner SA; Knepper SM; Kerwin JF
    J Med Chem; 1996 Sep; 39(20):4116-9. PubMed ID: 8831777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
    Imanishi M; Nakajima Y; Tomishima Y; Hamashima H; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Aug; 51(15):4804-22. PubMed ID: 18651730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
    Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
    J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
    Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.
    Konkel MJ; Wetzel JM; Cahir M; Craig DA; Noble SA; Gluchowski C
    J Med Chem; 2005 Apr; 48(8):3076-9. PubMed ID: 15828846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.